Board changes at Moolec Science (NASDAQ: MLEC) as Core joins

Rhea-AI Filing Summary

Moolec Science SA reported changes to its Board of Directors. Daniel Core has been appointed to the Board, effective February 25, 2025, and will also serve on the Audit Committee and the Compensation Committee. On the same date, directors Aimar Dimo and Gloria Montaron Estrada resigned from the Board. The company thanked both departing directors for their service. Moolec Science focuses on engineering plants and microbes to produce scalable protein ingredients for the global food system and is listed on Nasdaq under the ticker MLEC.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of February 2026

Commission File Number: 001-41586

MOOLEC SCIENCE SA

(Exact name of Registrant as Specified in Its Charter)

89 Nexus Way, Camana Bay

Grand Cayman KY1-9009

Cayman Islands

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒       Form 40-F ☐

EXPLANATORY NOTE

The information contained in this Form 6-K and any exhibits hereto shall be deemed to be incorporated by reference into the Company’s registration statement on Form S-8 (Registration No. 333-282263).

1

EXHIBIT INDEX

The following exhibit is filed as part of this Form 6-K:

Exhibit		Description
99.1		Press Release dated February 25, 2025, titled “Moolec Science SA Announces Changes to Board of Directors

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Moolec Science SA
	(registrant)
Date: February 26, 2026	By:	/s/ Alejandro Antalich
	Name:	Alejandro Antalich
	Title:	Chief Executive Officer

3

Exhibit 99.1

Moolec Science SA Announces Changes to Board of Directors

Moolec Science SA (NASDAQ: MLEC) (the “Company”), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced changes to the composition of its Board of Directors.

Appointment of Director

Daniel Core has been appointed to the Company’s Board of Directors, effective February 25, 2025. Mr. Core has also been appointed as a member of the Audit Committee and the Compensation Committee of the Board. 

Daniel Core is a U.S.-based quality and operations professional with more than three decades of experience in industrial manufacturing environments. His background includes quality leadership roles across multinational and precision manufacturing organizations, with a focus on operational discipline, compliance, and process integrity.

Mr. Core has held quality assurance and quality leadership positions with organizations including Illinois Tool Works, MW Components, Aptix, and Stanley Black & Decker. His experience spans the implementation and oversight of established quality management systems and regulatory frameworks commonly applied in regulated manufacturing sectors. He has extensive experience supporting internal and external audit processes, strengthening quality systems, and contributing to continuous improvement initiatives focused on risk reduction, cost discipline, and operational efficiency. Mr. Core currently serves in a quality leadership role within the manufacturing sector in New England.

He brings a disciplined, systems-oriented perspective to Board discussions, informed by hands-on experience with quality governance, compliance environments, and operational risk management.

Resignation of Directors

Aimar Dimo and Gloria Montaron Estrada have each resigned from the Company’s Board of Directors, effective February 25, 2025.

The Company sincerely thanks Mr. Dimo and Ms. Montaron Estrada for their dedicated service and valuable contributions to the Company and its shareholders during their tenure.

About Moolec Science SA

Moolec Science is an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food system. By integrating Molecular Farming and precision fermentation, Moolec combines the cost efficiency of crops with the functionality and nutrition of animal proteins, creating sustainable and commercially viable ingredients. The Company’s diversified pipeline includes alternative proteins, bioactive compounds, nutritional oils, and biological inputs for regenerative agriculture. Moolec has a robust intellectual property portfolio with more than 52 granted and pending patents across multiple technology platforms. With operations spanning the United States, Europe and South America, Moolec is advancing a seed-to-ingredient approach designed to transform the future of food production. Moolec is publicly listed on Nasdaq under the ticker “MLEC.” For more information, please visit www.moolecscience.com and ir.moolecscience.com.

Forward Looking Statements

This press release contains “forward-looking statements.” Forward-looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,” “expect,” “estimate,” “plan,” “outlook,” and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements with respect to performance, prospects, revenues, and other aspects of the business of Moolec are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors, about which we cannot be certain. We cannot assure you that the forward-looking statements in this press release will prove accurate. These forward-looking statements are subject to a number of significant risks and uncertainties that could cause actual results to differ materially from expected results, including, among others, changes in applicable laws or regulations, the possibility that Moolec may be adversely affected by economic, business and/or other competitive factors, costs related to the scaling up of Moolec’s business and other risks and uncertainties, including those included under the header “Risk Factors” in Moolec’s Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (“SEC”), as well as Moolec’s other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Accordingly, you should not put undue reliance on these statements.

Moolec Science’s Contacts:

● Investor Relations inquiries: ir@moolecscience.com

FAQ

What board changes did Moolec Science (MLEC) announce in this 6-K?

Moolec Science announced that Daniel Core joined its Board of Directors, while Aimar Dimo and Gloria Montaron Estrada resigned, all effective February 25, 2025. The company expressed appreciation for the departing directors’ service to the company and its shareholders during their respective tenures.

Who is Daniel Core, the new director at Moolec Science (MLEC)?

Daniel Core is a U.S.-based quality and operations professional with more than three decades of experience in industrial manufacturing. His background includes leadership roles at Illinois Tool Works, MW Components, Aptix, and Stanley Black & Decker, focused on quality systems, compliance, and operational risk management.

What committees will new director Daniel Core serve on at Moolec Science (MLEC)?

Daniel Core has been appointed to both the Audit Committee and the Compensation Committee of Moolec Science’s Board of Directors. His experience with quality management systems, regulatory frameworks, audits, and operational discipline is expected to inform his work on financial oversight and executive compensation matters.

Which Moolec Science (MLEC) directors resigned and when were their resignations effective?

Directors Aimar Dimo and Gloria Montaron Estrada resigned from Moolec Science’s Board of Directors, effective February 25, 2025. The company publicly thanked them for their dedicated service and contributions to Moolec’s development and to its shareholders over the course of their board tenures.

What does Moolec Science (MLEC) focus on in its business operations?

Moolec Science engineers plants and microbes to create scalable protein solutions for the global food system. It combines Molecular Farming with precision fermentation to produce alternative proteins, bioactive compounds, nutritional oils, and biological inputs for regenerative agriculture across operations in the United States, Europe, and South America.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 PRESS RELEASE DATED FEBRUARY 25, 2025, TITLED "MOOLEC SCIENCE SA ANNOUNCES CHANG 9.3 KB